Cancer / Oncology

MiRXES Secures US$77 Million To Accelerate Multi-Cancer Early Detection

 MiRXES Pte Ltd, a biotechnology company focused on improving and saving lives with RNA-powered disease early detection tests, announced today it has ...

 July 12, 2021 | News

Elekta optimizes treatment times for cancer patients

For the last several years, Elekta (EKTA-B.ST) has invested substantially in digitized service solutions to keep critical treatment machines up and running...

 July 07, 2021 | News

Y-Biologics & Pierre Fabre enter into an agreement in the field of immuno-oncology

These antibodies have been functionally validated by the Pierre Fabre R&D teams for their specific properties on a pivotal immuno-oncology target actin...

 July 06, 2021 | News

BioMed X & Merck KGaA, Darmstad Launch New Research Program in Oncology

  BioMed X Institute expands its collaboration with Merck KGaA, Darmstadt, Germany to a total of eight research programs. Call for application of ...

 July 05, 2021 | News

QIAGEN Forms Strategic Alliance With Sysmex Corporation

Frankfurt Prime Standard:QIA) today announced a global strategic alliance with Japan’s Sysmex Corporation (Tokyo Stock Exchange, First Section [Ticke...

 July 02, 2021 | News

I-Mab Announces Multiple Advancements of 4-1BB Bispecific Antibody Portfolio

First patient dosed in U.S. phase 1 clinical trial of TJ-CD4B/ABL111 in patients with advanced or metastatic solid tumors China sites to join the d...

 July 02, 2021 | News

OnCusp Therapeutics Commences Operations to Advance Innovative Oncology Therapies

OnCusp successfully closed its seed round financing of $25 million on April 1, 2021, led by Sequoia Capital and Biotrack Capital, followed b...

 July 01, 2021 | News

B dot Medical to test on a compact proton cancer therapy system

  To Realize Compact and Low-cost Proton Therapy System -   B dot Medical Inc. has confirmed the superconductivity of a superconducting be...

 June 28, 2021 | News

GenesisCare Expands their MR-guided Radiotherapy Reach

ViewRay, Inc. (NASDAQ: VRAY) today announced that GenesisCare has entered into a master purchase agreement for up to 14 MRIdian® MR-Guided Therapy Syst...

 June 25, 2021 | News

Singapore to Introduce Fertility Preservation Services for Cancer Patients

Cancer treatments such as chemotherapy and radiation therapy can affect a woman's fertility by impacting the ovaries and other essential reproductive organ...

 June 23, 2021 | News

Shimadzu ,Rakuten Medical to support cancer treatment by photoimmunotherapy

Therapies developed on the Illuminox platform involve administering a targeting moiety conjugated with one or more dyes, which is illuminated by light at a...

 June 18, 2021 | News

Debiopharm and Ubix Therapeutics o Develop a New Anti-Cancer Modality -

Debiopharm (www.debiopharm.com), a Swiss-based global biopharmaceutical company and Ubix Therapeutics (en.ubixtrx.com), a South Korea-based biotech co...

 June 17, 2021 | News

Harbour BioMed and Dana-Farber to Advance Novel Biotherapies for Cancer Treatment

Harbour BioMed scientists and Dana-Farber researchers will be working together to develop novel oncologic drugs, including bispecific antibodies and CAR-T ...

 June 16, 2021 | News

IN3BIO gains approval for Phase I/II clinical trial

IN3BIO will trial its innovative anti-EGF vaccine IN01, in combination with small molecule inhibitors (SMIs) in patients suffering from KRAS or NRAS (...

 June 10, 2021 | News


News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close